| Overexpression of Cytoplasmic TcSIR2RP1 and Mitochondrial TcSIR2RP3 Impacts on Trypanosoma cruzi Growth and Cell Invasion C Ritagliati, VL Alonso, R Manarin, P Cribb, EC Serra PLoS Neglected Tropical Diseases 9 (4), e0003725, 2015 | 41 | 2015 |
| Lysine acetylation: elucidating the components of an emerging global signaling pathway in trypanosomes VL Alonso, EC Serra BioMed Research International 2012, 2012 | 31 | 2012 |
| Effect directed synthesis of a new tyrosinase inhibitor with anti-browning activity I Cabezudo, IA Ramallo, VL Alonso, RLE Furlan Food chemistry 341, 128232, 2021 | 29 | 2021 |
| Overexpression of bromodomain factor 3 in Trypanosoma cruzi (TcBDF3) affects differentiation of the parasite and protects it against bromodomain inhibitors VL Alonso, C Ritagliati, P Cribb, JA Cricco, EC Serra The FEBS Journal 283 (11), 2051-2066, 2016 | 26 | 2016 |
| A Bioactive Trypanosoma cruzi Bromodomain Inhibitor from Chemically Engineered Extracts IA Ramallo, VL Alonso, F Rua, E Serra, RLE Furlan ACS combinatorial science 20 (4), 220-228, 2018 | 24 | 2018 |
| Trypanosoma cruzi bromodomain factor 3 binds acetylated α-tubulin and concentrates in the flagellum during metacyclogenesis VL Alonso, GV Villanova, C Ritagliati, MC Machado Motta, P Cribb, ... Eukaryotic Cell 13 (6), 822-831, 2014 | 23 | 2014 |
| Discovery of a biologically active bromodomain inhibitor by target-directed dynamic combinatorial chemistry P García, VL Alonso, E Serra, AM Escalante, RLE Furlan ACS medicinal chemistry letters 9 (10), 1002-1006, 2018 | 20 | 2018 |
| Construction of three new Gateway® expression plasmids for Trypanosoma cruzi VL Alonso, C Ritagliati, P Cribb, EC Serra Memórias do Instituto Oswaldo Cruz 109, 1081-1085, 2014 | 20 | 2014 |
| Development and in vitro/in vivo evaluation of a novel benznidazole liquid dosage form using a quality‐by‐design approach HF Santos Souza, D Real, D Leonardi, SC Rocha, V Alonso, E Serra, ... Tropical Medicine & International Health 22 (12), 1514-1522, 2017 | 18 | 2017 |
| Glycosomal bromodomain factor 1 from Trypanosoma cruzi enhances trypomastigote cell infection and intracellular amastigote growth C Ritagliati, GV Villanova, VL Alonso, AA Zuma, P Cribb, MCM Motta, ... Biochemical Journal 473 (1), 73-85, 2016 | 18 | 2016 |
| Overexpression of Trypanosoma cruzi High Mobility Group B protein (TcHMGB) alters the nuclear structure, impairs cytokinesis and reduces the parasite infectivity LE Tavernelli, MCM Motta, CS Gonçalves, MS da Silva, MC Elias, ... Scientific Reports 9 (1), 192, 2019 | 17 | 2019 |
| Trypanosoma cruzi High Mobility Group B (TcHMGB) can act as an inflammatory mediator on mammalian cells P Cribb, V Perdomo, VL Alonso, R Manarin, J Barrios-Payan, ... PLoS Neglected Tropical Diseases 11 (2), e0005350, 2017 | 12 | 2017 |
| Essential Bromodomain TcBDF2 as a Drug Target against Chagas Disease A Pezza, LE Tavernelli, VL Alonso, V Perdomo, R Gabarro, R Prinjha, ... ACS Infectious Diseases 8 (5), 1062-1074, 2022 | 9 | 2022 |
| Ultrastructure Expansion Microscopy (U-ExM) in Trypanosoma cruzi: localization of tubulin isoforms and isotypes VL Alonso Parasitology Research 121 (10), 3019-3024, 2022 | 6 | 2022 |
| Alpha-Tubulin Acetylation in Trypanosoma cruzi: A Dynamic Instability of Microtubules Is Required for Replication and Cell Cycle Progression VL Alonso, ME Carloni, CS Gonçalves, G Martinez Peralta, ME Chesta, ... Frontiers in Cellular and Infection Microbiology 11, 642271, 2021 | 5 | 2021 |
| Aim for the readers! Bromodomains as new targets against Chagas’ disease VL Alonso, LE Tavernelli, A Pezza, P Cribb, C Ritagliati, E Serra Current Medicinal Chemistry 26 (36), 6544-6563, 2019 | 5 | 2019 |
| Update on the biological relevance of lysine acetylation as a novel drug target in trypanosomatids GM Peralta, E Serra, VL Alonso Current Medicinal Chemistry 29 (20), 3638-3659, 2022 | 4 | 2022 |
| In vitro drug screening against all life cycle stages of trypanosoma cruzi using parasites expressing β-galactosidase VL Alonso, R Manarin, V Perdomo, E Gulin, E Serra, P Cribb JoVE (Journal of Visualized Experiments), e63210, 2021 | 4 | 2021 |
| Optimization and biological validation of an in vitro assay using the transfected Dm28c/pLacZ Trypanosoma cruzi strain JEN Gulin, DM Rocco, V Alonso, P Cribb, J Altcheh, F García-Bournissen Biology Methods and Protocols 6 (1), bpab004, 2021 | 2 | 2021 |
| Identification of novel Bromodomain inhibitors of Trypanosoma cruzi Bromodomain Factor 2 (TcBDF2) using a fluorescence polarization-base high-throughput assay EC Serra, L Tavernelli, VL Alonso, I Peña, E Rodríguez Araya, R Manarin, ... bioRxiv, 2024.02. 16.580721, 2024 | | 2024 |
